100
Participants
Start Date
July 31, 2007
Primary Completion Date
December 1, 2019
Study Completion Date
December 1, 2019
No intervention
Observational, epidemiological, prognosis study; no drug tested; only laboratory analysis and diagnostic interventions done.
Department of Neurology, University Hospital Sestre Milosrdnice, Zagreb
Department of Neurology, Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Department of Neurology, Allgemeines Krankenhaus Celle, Celle
Department of Neurology, University Tuebingen, Tübingen
Department of Neurology, Klinikum Hohe Warte, Bayreuth
Dept. of Neurology, Ökumenisches Hainich Klinikum gGmbH, Mühlhausen
Universitätsklinikum für Neurologie, Graz
Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires, Lyon
Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university, Tbilisi
Charite Campus Benjamin Franklin, Dept. of Neurology, Berlin
Department of Neurology, Klinikum Chemnitz gGmbH, Chemnitz
Department of Neurology, Universitaetsklinikum Carl Gustav Carus, Dresden
Heinrich-Heine-University Duesseldorf, Dept. of Neurology, Düsseldorf
University of Giessen-Marburg Dept. of Neurology, Giessen
Department of Neurology, Universitaetsklinikum Jena, Jena
Department of Neurology, Universitaetsklinikum Leipzig, Leipzig
Ludwig-Maximilians-University of Munich, Klinikum München-Großhadern, Dept. of Neurology, München
University of Ulm, Department of Neurology, Ulm
Institute of Psychiatry and Neurology, Dept. of Neurology, Warsaw
Centro Hospitalar de Lisboa Central, Servico de Neurologia, Lisbon
Shire Human Genetic Therapies, Inc.
INDUSTRY
CENTOGENE GmbH Rostock
INDUSTRY